Drug intelligence / Profile preview

papazol

Development stage
Unknown
Lead developer
Irbit Chemical Pharmaceutical Plant
Modality
Small Molecules
Administration
Oral
01

Overview

Papazol is a fixed-dose combination pharmaceutical product consisting of bendazol (also known as dibazole) and papaverine hydrochloride. It is primarily manufactured and marketed in Russia and other CIS countries as a myotropic antispasmodic and vasodilator. Papaverine, an opium alkaloid derivative, acts as a non-selective phosphodiesterase inhibitor, increasing intracellular cAMP and leading to smooth muscle relaxation. Bendazol is a benzimidazole derivative that exerts direct vasodilatory effects on smooth muscles and possesses mild adaptogenic and immunostimulating properties. The combination is indicated for the symptomatic relief of arterial hypertension, spasms of peripheral arteries, and spasms of smooth muscles in the gastrointestinal tract, such as pylorospasm and colitis.

Brand names
Papazol
Other names
bendazol + papaverinedibazole + papaverineПапазол
02

Targets

PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on papazol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on papazol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call